{"id":2040,"date":"2025-03-12T13:06:33","date_gmt":"2025-10-07T09:30:03","guid":{"rendered":"https:\/\/www.elixirr.com\/en-gb\/?post_type=case_study&p=2040"},"modified":"2025-10-29T15:29:42","modified_gmt":"2025-10-29T15:29:42","slug":"accelerating-fda-approval-to-unlock-1m-in-daily-revenue","status":"publish","type":"case_study","link":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/","title":{"rendered":"Accelerating FDA approval to unlock $1M in daily revenue"},"content":{"rendered":"\n
\n
\n

A biopharmaceutical company faced an impossible FDA submission deadline. Sceptical teams, weighed down by distrust and limiting beliefs, transformed through breakthrough performance methodology\u2014delivering the submission 45 days early, saving $1M per day and earning a unanimous FDA approval.<\/p>\n

    \n
  • Outcome 1: Reduced the drug submission to the FDA by 45 days that original timeline<\/li>\n
  • Outcome 2: Saved an estimated $1 million (USD) a day<\/li>\n
  • Outcome 3: Achieved FDA approval and launch of the drug sooner than they believed they could<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n
    \n
    \n

    \n The challenge<\/h2>
    \n
    \n

    In the highly regulated and competitive biopharmaceutical industry, speed to market is critical<\/span>\u2014<\/span>not just for business success but for the patients who depend on new treatments.<\/span>\u00a0With millions of dollars and countless lives at stake, t<\/span>he client<\/span>\u00a0turned to\u00a0<\/span>us<\/span>\u00a0to drive a fundamental transformation in how they worked,\u00a0<\/span>collaborated<\/span>\u00a0and delivered results.<\/span><\/span>\u00a0<\/span><\/p>\n

    A biopharmaceutical company developing a breakthrough drug for motor function impairment faced a major hurdle<\/span>\u2014<\/span>it was far behind schedule.\u00a0<\/span>A<\/span>\u00a0cross-functional team<\/span>\u00a0consisting of leaders<\/span>\u00a0from testing to quality control<\/span>\u00a0doubted they could meet the CEO<\/span>\u2019<\/span>s aggressive\u00a0<\/span>deadline<\/span>s<\/span>,\u00a0<\/span>and<\/span>\u00a0were\u00a0<\/span>already six months behind.\u00a0<\/span><\/span>\u00a0<\/span><\/p>\n <\/div>\n <\/div>\n <\/div> <\/div>\n<\/section>\n\n\n\n

    \n
    \n

    \n The approach<\/h2>
    \n
    \n

    Together, we helped them break free from existing assumptions, transforming scepticism into ownership. We reimagined their strategies and rallied behind a bold new vision:\u00a0<\/span>One Team, One Dream, The Unreachable is Our Routine.<\/span><\/i>\u00a0<\/span><\/p>\n

    With this new unified approach, our client set a more ambitious goal\u2014delivering the drug 45 days ahead of schedule. Through enhanced transparency, faster decision-making and a culture of true collaboration, we turned what seemed like an impossible deadline into a resounding success.<\/span>\u00a0<\/span><\/p>\n <\/div>\n <\/div>\n <\/div> <\/div>\n<\/section>\n\n\n\n

    \n
    \n

    \n The value delivered<\/h2>
    \n
    \n

    Our client<\/span>\u00a0submitted<\/span>\u00a0the drug to the FDA, beating the original deadline by six weeks and saving an estimated $1 million per day. They also delivered a high-quality submission, earning a unanimous 12-0 approval recommendation from an independent panel<\/span>\u2014<\/span>an impressive industry feat. Most importantly,\u00a0<\/span>our client<\/span>\u00a0brought a life-changing drug to\u00a0<\/span>mark<\/span>et<\/span>\u00a0fas<\/span>ter. Beyond this success, they applied their newfound approach to future projects, creating lasting impact across the company. This breakthrough not only met but exceeded expectations, proving that bold goals are achievable with the right mindset and strategy.<\/span><\/span>\u00a0<\/span><\/p>\n <\/div>\n <\/div>\n <\/div> <\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":55120,"template":"","related_service":[50],"related_industry":[44],"class_list":["post-2040","case_study","type-case_study","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nAccelerating FDA approval to unlock $1M in daily revenue - Elixirr<\/title>\n<meta name=\"description\" content=\"Elixirr helped a biotech company submit its drug ahead of schedule \u2014 unlocking an estimated $1 M per day in revenue and securing rapid-track approval.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Accelerating FDA approval to unlock $1M in daily revenue\" \/>\n<meta property=\"og:description\" content=\"Elixirr helped a biotech company submit its drug ahead of schedule \u2014 unlocking an estimated $1 M per day in revenue and securing rapid-track approval.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/\" \/>\n<meta property=\"og:site_name\" content=\"Elixirr\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-29T15:29:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"820\" \/>\n\t<meta property=\"og:image:height\" content=\"492\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/\",\"url\":\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/\",\"name\":\"Accelerating FDA approval to unlock $1M in daily revenue - Elixirr\",\"isPartOf\":{\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg\",\"datePublished\":\"2025-10-07T09:30:03+00:00\",\"dateModified\":\"2025-10-29T15:29:42+00:00\",\"description\":\"Elixirr helped a biotech company submit its drug ahead of schedule \u2014 unlocking an estimated $1 M per day in revenue and securing rapid-track approval.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#primaryimage\",\"url\":\"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg\",\"contentUrl\":\"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg\",\"width\":820,\"height\":492},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.elixirr.com\/en-gb\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Case Studies\",\"item\":\"https:\/\/www.elixirr.com\/en-gb\/case-studies\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Accelerating FDA approval to unlock $1M in daily revenue\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/#website\",\"url\":\"https:\/\/www.elixirr.com\/en-gb\/\",\"name\":\"Elixirr\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.elixirr.com\/en-gb\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/#organization\",\"name\":\"Elixirr\",\"alternateName\":\"Elixirr International PLC\",\"url\":\"https:\/\/www.elixirr.com\/en-gb\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/11\/elixirr-logo.png\",\"contentUrl\":\"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/11\/elixirr-logo.png\",\"width\":200,\"height\":200,\"caption\":\"Elixirr\"},\"image\":{\"@id\":\"https:\/\/www.elixirr.com\/en-gb\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Accelerating FDA approval to unlock $1M in daily revenue - Elixirr","description":"Elixirr helped a biotech company submit its drug ahead of schedule \u2014 unlocking an estimated $1 M per day in revenue and securing rapid-track approval.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/","og_locale":"en_US","og_type":"article","og_title":"Accelerating FDA approval to unlock $1M in daily revenue","og_description":"Elixirr helped a biotech company submit its drug ahead of schedule \u2014 unlocking an estimated $1 M per day in revenue and securing rapid-track approval.","og_url":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/","og_site_name":"Elixirr","article_modified_time":"2025-10-29T15:29:42+00:00","og_image":[{"width":820,"height":492,"url":"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/","url":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/","name":"Accelerating FDA approval to unlock $1M in daily revenue - Elixirr","isPartOf":{"@id":"https:\/\/www.elixirr.com\/en-gb\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#primaryimage"},"image":{"@id":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg","datePublished":"2025-10-07T09:30:03+00:00","dateModified":"2025-10-29T15:29:42+00:00","description":"Elixirr helped a biotech company submit its drug ahead of schedule \u2014 unlocking an estimated $1 M per day in revenue and securing rapid-track approval.","breadcrumb":{"@id":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#primaryimage","url":"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg","contentUrl":"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg","width":820,"height":492},{"@type":"BreadcrumbList","@id":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elixirr.com\/en-gb\/"},{"@type":"ListItem","position":2,"name":"Case Studies","item":"https:\/\/www.elixirr.com\/en-gb\/case-studies\/"},{"@type":"ListItem","position":3,"name":"Accelerating FDA approval to unlock $1M in daily revenue"}]},{"@type":"WebSite","@id":"https:\/\/www.elixirr.com\/en-gb\/#website","url":"https:\/\/www.elixirr.com\/en-gb\/","name":"Elixirr","description":"","publisher":{"@id":"https:\/\/www.elixirr.com\/en-gb\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elixirr.com\/en-gb\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.elixirr.com\/en-gb\/#organization","name":"Elixirr","alternateName":"Elixirr International PLC","url":"https:\/\/www.elixirr.com\/en-gb\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.elixirr.com\/en-gb\/#\/schema\/logo\/image\/","url":"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/11\/elixirr-logo.png","contentUrl":"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/11\/elixirr-logo.png","width":200,"height":200,"caption":"Elixirr"},"image":{"@id":"https:\/\/www.elixirr.com\/en-gb\/#\/schema\/logo\/image\/"}}]}},"card":"<article class=\"wp-component-card edwp-component wp-component-card--case_study wp-component-card--link js-card-link\n edwp-fade-in\">\n <figure class=\"wp-component-card__image-wrapper\">\n <img width=\"820\" height=\"492\" src=\"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg\" class=\"wp-component-card__image\" alt=\"\" decoding=\"async\" srcset=\"https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440.jpg 820w, https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440-300x180.jpg 300w, https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440-768x461.jpg 768w, https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440-87x52.jpg 87w, https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440-319x191.jpg 319w, https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440-479x287.jpg 479w, https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440-567x340.jpg 567w, https:\/\/www.elixirr.com\/en-gb\/wp-content\/uploads\/2025\/10\/Accelerating-FDA-approval2400x1440-767x460.jpg 767w\" sizes=\"(max-width: 820px) 100vw, 820px\" \/> <div class=\"wp-component-card__preview-icon\">\n <span class='edwp-svg '><svg width=\"47\" height=\"47\" viewBox=\"0 0 47 47\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n<g>\n<path d=\"M23.4141 0.539062C36.1232 0.539183 46.4258 10.8416 46.4258 23.5508C46.4257 36.2599 36.1231 46.5624 23.4141 46.5625C10.7049 46.5625 0.402465 36.2599 0.402344 23.5508C0.402344 10.8415 10.7048 0.539062 23.4141 0.539062ZM23.4141 1.68945C11.3606 1.68945 1.55273 11.4974 1.55273 23.5508C1.55286 35.6041 11.3607 45.4111 23.4141 45.4111C35.4673 45.411 45.2743 35.604 45.2744 23.5508C45.2744 11.4974 35.4674 1.68957 23.4141 1.68945Z\" fill=\"currentColor\"\/>\n<path d=\"M19.2841 33.6992C18.9579 33.6986 18.6374 33.6111 18.3543 33.4454C17.7167 33.0759 17.3203 32.3585 17.3203 31.5797V15.8189C17.3203 15.0379 17.7167 14.3227 18.3543 13.9531C18.6442 13.7827 18.9735 13.6951 19.3078 13.6994C19.6421 13.7037 19.9692 13.7998 20.2548 13.9776L33.4237 22.0406C33.6981 22.2166 33.9244 22.461 34.0812 22.751C34.238 23.0409 34.3203 23.3668 34.3203 23.6982C34.3203 24.0295 34.238 24.3555 34.0812 24.6454C33.9244 24.9353 33.6981 25.1798 33.4237 25.3558L20.2527 33.421C19.9604 33.6017 19.6256 33.6979 19.2841 33.6992Z\" fill=\"currentColor\"\/>\n<\/g>\n<\/svg>\n<\/span> <\/div>\n <\/figure>\n <div class=\"wp-component-card__content edwp-row-load\">\n <p class=\"wp-component-card__eyebrow\">\n Breakthrough Imperatives <\/p>\n <a href='https:\/\/www.elixirr.com\/en-gb\/case-studies\/accelerating-fda-approval-to-unlock-1m-in-daily-revenue\/' class='wp-component-card__title'>\n <h2>\n Accelerating FDA approval to unlock $1M in daily revenue\n <\/h2>\n <\/a> <div class=\"wp-component-card__meta\">\n <p class=\"wp-component-card__date\">\n 12 March 2025 <\/p>\n <div class=\"wp-component-card__terms\">\n <div class=\"wp-component-tags edwp-component\">\n <div class=\"wp-component-tags__tag\">\n Healthcare & Pharmaceuticals <\/div>\n <div class=\"wp-component-tags__tag\">\n Breakthrough Imperatives <\/div>\n <\/div>\n <\/div>\n <\/div>\n <div class=\"wp-component-card__button-wrapper\">\n <button class=\"btn btn--link arrow wp-component-card__button\">\n Read more <span class='edwp-svg '><svg width=\"20\" height=\"20\" viewBox=\"0 0 20 20\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n<g id=\"Lg\">\n<path id=\"Vector\" d=\"M1.12509 9.50162H15.8648L9.43259 3.06941C9.374 3.0113 9.3275 2.94216 9.29576 2.86599C9.26403 2.78981 9.24769 2.70811 9.24769 2.62559C9.24769 2.54307 9.26403 2.46137 9.29576 2.38519C9.3275 2.30902 9.374 2.23988 9.43259 2.18177C9.54971 2.06535 9.70814 2 9.87328 2C10.0384 2 10.1969 2.06535 10.314 2.18177L17.8151 9.6829C17.8737 9.74101 17.9202 9.81014 17.9519 9.88632C17.9837 9.96249 18 10.0442 18 10.1267C18 10.2092 17.9837 10.2909 17.9519 10.3671C17.9202 10.4433 17.8737 10.5124 17.8151 10.5705L10.314 18.0717C10.1975 18.1871 10.0404 18.2522 9.87641 18.2529C9.79414 18.2534 9.71259 18.2376 9.63643 18.2065C9.56027 18.1754 9.491 18.1296 9.43259 18.0717C9.374 18.0135 9.3275 17.9444 9.29576 17.8682C9.26403 17.7921 9.24769 17.7104 9.24769 17.6278C9.24769 17.5453 9.26403 17.4636 9.29576 17.3874C9.3275 17.3113 9.374 17.2421 9.43259 17.184L15.8711 10.7518H1.12509C0.959309 10.7518 0.800312 10.686 0.683084 10.5687C0.565857 10.4515 0.5 10.2925 0.5 10.1267C0.5 9.96093 0.565857 9.80193 0.683084 9.68471C0.800312 9.56748 0.959309 9.50162 1.12509 9.50162Z\" fill=\"#1D0F25\"\/>\n<\/g>\n<\/svg>\n<\/span> <\/button>\n <\/div>\n <\/div>\n<\/article>\n","_links":{"self":[{"href":"https:\/\/www.elixirr.com\/en-gb\/wp-json\/wp\/v2\/case_study\/2040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elixirr.com\/en-gb\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/www.elixirr.com\/en-gb\/wp-json\/wp\/v2\/types\/case_study"}],"author":[{"embeddable":true,"href":"https:\/\/www.elixirr.com\/en-gb\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elixirr.com\/en-gb\/wp-json\/wp\/v2\/media\/55120"}],"wp:attachment":[{"href":"https:\/\/www.elixirr.com\/en-gb\/wp-json\/wp\/v2\/media?parent=2040"}],"wp:term":[{"taxonomy":"related_service","embeddable":true,"href":"https:\/\/www.elixirr.com\/en-gb\/wp-json\/wp\/v2\/related_service?post=2040"},{"taxonomy":"related_industry","embeddable":true,"href":"https:\/\/www.elixirr.com\/en-gb\/wp-json\/wp\/v2\/related_industry?post=2040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}